{"mainPropery":{"diseaseId":6347,"diseaseName":"Eosinophilic cystitis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6347/eosinophilic-cystitis","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"UMLS","identifierId":"C0742965"}]},"diseaseCategories":[],"organizations":[{"resourceID":191,"resourceName":"American Partnership For Eosinophilic Disorders","abbreviation":"","address1":"PO Box 29545","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30359","country":"United States","phone":"713-493-7749","tty":"","tollFree":"","fax":"","email":"mail@apfed.org","url":"http://www.apfed.org","freeText":""},{"resourceID":358,"resourceName":"International Eosinophil Society","abbreviation":"","address1":"555 East Wells Street, Suite 1100","address2":"","address3":"","address4":"","address5":"","city":"Milwaukee","state":"WI","zip":"53202","country":"United States","phone":"414-276-6445","tty":"","tollFree":"","fax":"","email":"info@eosinophil-society.org/","url":"http://www.eosinophil-society.org/","freeText":""},{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=eosinophilic+cystitis+%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Eosinophilic cystitis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4597,"questionText":"What is eosinophilic cystitis?","answerText":"<strong>Eosinophilic cystitis (EC)</strong> is a rare inflammatory <a href=\"http://www.nlm.nih.gov/medlineplus/bladderdiseases.html\" target=\"_blank\">bladder condition</a> caused by the build up of <a href=\"http://www.nlm.nih.gov/medlineplus/eosinophilicdisorders.html\" target=\"_blank\">eosinophils</a> in the bladder. The exact cause of this condition is not known. However, EC has been found in those with <a href=\"http://www.nlm.nih.gov/medlineplus/allergy.html\" target=\"_blank\">allergies</a> and&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/asthma.html\" target=\"_blank\">asthma</a>, and in those with a history of bladder trauma or infection, open bladder surgery, or surgery for a bladder tumor. EC has also been found in those who take certain medications.[3568][7592]","dateModified":"2014-08-20T00:00:00"},"basicQuestions":[{"questionId":4598,"questionText":"What are the signs and symptoms of eosinophilic cystitis?","answerText":"Common symptoms include <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003140.htm\" target=_blank>urinary frequency</a>, painful urination, blood in the urine, and&nbsp;abdominal/pelvic pain.&nbsp;Other less common symptoms include <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003141.htm\" target=_blank>excessive urination during the night</a> and <a href=\"http://kidney.niddk.nih.gov/kudiseases/pubs/UrinaryRetention/#symptoms\" target=_blank>urinary retention</a>. Many of the symptoms commonly seen in EC mimic symptoms seen in other conditions. Rare features include gastrointestinal symptoms because of <a href=\"http://apfed.org/drupal/drupal/what_are_egids\" target=_blank>eosinophilic gastroenteritis</a>, skin rash, and the passage of air in the urine (pneumaturia).&nbsp;EC has been observed in 2% of patients&nbsp;with superficial transitional cell carcinoma (bladder cancer).[3568] ","dateModified":"2011-06-02T15:34:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3568,"authors":"Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS","articleTitle":"Eosinophilic cystitis and its management","bookWebsiteJournalTitle":"Int J Clin Pract","date":"2005","volume":"59(3)","pages":"356-60","url":"http://www.ncbi.nlm.nih.gov/pubmed/15857336","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3569,"authors":"van den Ouden D","articleTitle":"Diagnosis and management of eosinophilic cystitis: a pooled analysis of 135 cases","bookWebsiteJournalTitle":"Eur Urol","date":"2000","volume":"37(4)","pages":"386-94","url":"http://www.ncbi.nlm.nih.gov/pubmed/10765067","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7659,"questionText":"What causes eosinophilic cystitis?","answerText":"The cause of eosinophilic cystitis remains unclear, although it has been associated with allergies, reactions to certain medications (antibiotics, chemotherapy), bladder trauma, bladder tumors, and parasitic infections.[3568][7592]","dateModified":"2014-08-20T13:42:00","resourceClassificationName":"Cause","references":[{"referenceId":3568,"authors":"Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS","articleTitle":"Eosinophilic cystitis and its management","bookWebsiteJournalTitle":"Int J Clin Pract","date":"2005","volume":"59(3)","pages":"356-60","url":"http://www.ncbi.nlm.nih.gov/pubmed/15857336","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7592,"authors":"","articleTitle":"Eosinophilic Cystitis","bookWebsiteJournalTitle":"American Partnership for Eosinophilic Disorders","date":"September 8, 2011","volume":"","pages":"","url":"http://apfed.org/drupal/drupal/eosinophilic_cystitis","dateAccessed":"2014-08-20T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4599,"questionText":"How might eosinophilic cystitis be treated?","answerText":"Any possible causative factors,&nbsp;should be avoided&nbsp;or discontinued, such as&nbsp;certain medications (tranilast, mitomycin C).&nbsp;Non-steroidal anti-inflammatory drugs (NSAIDs),&nbsp;such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682878.html\" target=\"_blank\">aspirin</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682159.html\" target=\"_blank\">ibuprofen</a>, and&nbsp;antihistamines have been used as the primary management of choice with good results. <a href=\"http://www.nlm.nih.gov/medlineplus/antibiotics.html\" target=\"_blank\">Antibiotics</a> are helpful, especially in those individuals with EC associated with <a href=\"http://www.nlm.nih.gov/medlineplus/urinarytractinfections.html\" target=\"_blank\">urinary tract infections</a>. Those&nbsp;who do not respond to&nbsp;NSAIDs and antihistamines have been treated with corticosteroids. Corticosteroids and antihistamines are used because they suppress the inflammatory reaction in the bladder.[3569] However, symptoms of EC may persist, despite steroid therapy. If symptoms persist after steroid therapy,&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682167.html\" target=\"_blank\">azathioprine</a>&nbsp;or <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html\" target=\"_blank\">cyclosporine</a> can be tried.[3569] Other treatments include <a href=\"http://www.mayoclinic.com/health/drug-information/DR600543\" target=\"_blank\">intravesical dimethylsulfoxide</a>,&nbsp;cyclosporin-A (immunosuppressant drug),&nbsp;and silver nitrate.[3568]<br />\r\n<br />\r\nIn those with bladder lesions, surgery has been successful. Few patients with progressive EC not responding to medical therapy or surgery may be considered for more radical procedures, such as partial/total cystectomy (surgical removal of all or part of the bladder).[3568]","dateModified":"2014-10-31T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":3568,"authors":"Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS","articleTitle":"Eosinophilic cystitis and its management","bookWebsiteJournalTitle":"Int J Clin Pract","date":"2005","volume":"59(3)","pages":"356-60","url":"http://www.ncbi.nlm.nih.gov/pubmed/15857336","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3569,"authors":"van den Ouden D","articleTitle":"Diagnosis and management of eosinophilic cystitis: a pooled analysis of 135 cases","bookWebsiteJournalTitle":"Eur Urol","date":"2000","volume":"37(4)","pages":"386-94","url":"http://www.ncbi.nlm.nih.gov/pubmed/10765067","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4600,"questionText":"What is the prognosis of&nbsp;eosinophilic cystitis?","answerText":"Most patients can be&nbsp;cured, but recurrence is a frequent finding. One study examined 118 patients who were treated for eosinophilic cystitis. Of these, 91 patients (77%) were cured, which was defined as the complete absence of symptoms in the short-term and long-term. However, the recurrence of symptoms has been noted in some affected individuals.[3569]&nbsp;Thus, those with EC require long-term follow-up with relevant blood tests, urine examination, appropriate imaging, and cystoscopy.[3568]","dateModified":"2011-06-02T15:54:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3568,"authors":"Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS","articleTitle":"Eosinophilic cystitis and its management","bookWebsiteJournalTitle":"Int J Clin Pract","date":"2005","volume":"59(3)","pages":"356-60","url":"http://www.ncbi.nlm.nih.gov/pubmed/15857336","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3569,"authors":"van den Ouden D","articleTitle":"Diagnosis and management of eosinophilic cystitis: a pooled analysis of 135 cases","bookWebsiteJournalTitle":"Eur Urol","date":"2000","volume":"37(4)","pages":"386-94","url":"http://www.ncbi.nlm.nih.gov/pubmed/10765067","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":30936,"abbreviatedInquiry":"I was diagnosed with eosinophilic cystitis. My doctor put me on steroids along with Allegra. I have been using&nbsp;these medications&nbsp;for five weeks now, and I see no signs of improvement.&nbsp;However, the side effects of the steroids&nbsp;are becoming too much for me.&nbsp;Is it likely that I can be cured of this disease?","caseQuestions":[{"questionId":4597,"questionText":"What is eosinophilic cystitis?","answerText":"<strong>Eosinophilic cystitis (EC)</strong> is a rare inflammatory <a href=\"http://www.nlm.nih.gov/medlineplus/bladderdiseases.html\" target=\"_blank\">bladder condition</a> caused by the build up of <a href=\"http://www.nlm.nih.gov/medlineplus/eosinophilicdisorders.html\" target=\"_blank\">eosinophils</a> in the bladder. The exact cause of this condition is not known. However, EC has been found in those with <a href=\"http://www.nlm.nih.gov/medlineplus/allergy.html\" target=\"_blank\">allergies</a> and&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/asthma.html\" target=\"_blank\">asthma</a>, and in those with a history of bladder trauma or infection, open bladder surgery, or surgery for a bladder tumor. EC has also been found in those who take certain medications.[3568][7592]","dateModified":"2014-08-20T00:00:00","references":[{"referenceId":3568,"authors":"Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS","articleTitle":"Eosinophilic cystitis and its management","bookWebsiteJournalTitle":"Int J Clin Pract","date":"2005","volume":"59(3)","pages":"356-60","url":"http://www.ncbi.nlm.nih.gov/pubmed/15857336","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7592,"authors":"","articleTitle":"Eosinophilic Cystitis","bookWebsiteJournalTitle":"American Partnership for Eosinophilic Disorders","date":"September 8, 2011","volume":"","pages":"","url":"http://apfed.org/drupal/drupal/eosinophilic_cystitis","dateAccessed":"2014-08-20T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4598,"questionText":"What are the signs and symptoms of eosinophilic cystitis?","answerText":"Common symptoms include <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003140.htm\" target=_blank>urinary frequency</a>, painful urination, blood in the urine, and&nbsp;abdominal/pelvic pain.&nbsp;Other less common symptoms include <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003141.htm\" target=_blank>excessive urination during the night</a> and <a href=\"http://kidney.niddk.nih.gov/kudiseases/pubs/UrinaryRetention/#symptoms\" target=_blank>urinary retention</a>. Many of the symptoms commonly seen in EC mimic symptoms seen in other conditions. Rare features include gastrointestinal symptoms because of <a href=\"http://apfed.org/drupal/drupal/what_are_egids\" target=_blank>eosinophilic gastroenteritis</a>, skin rash, and the passage of air in the urine (pneumaturia).&nbsp;EC has been observed in 2% of patients&nbsp;with superficial transitional cell carcinoma (bladder cancer).[3568] ","dateModified":"2011-06-02T15:34:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3568,"authors":"Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS","articleTitle":"Eosinophilic cystitis and its management","bookWebsiteJournalTitle":"Int J Clin Pract","date":"2005","volume":"59(3)","pages":"356-60","url":"http://www.ncbi.nlm.nih.gov/pubmed/15857336","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3569,"authors":"van den Ouden D","articleTitle":"Diagnosis and management of eosinophilic cystitis: a pooled analysis of 135 cases","bookWebsiteJournalTitle":"Eur Urol","date":"2000","volume":"37(4)","pages":"386-94","url":"http://www.ncbi.nlm.nih.gov/pubmed/10765067","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4599,"questionText":"How might eosinophilic cystitis be treated?","answerText":"Any possible causative factors,&nbsp;should be avoided&nbsp;or discontinued, such as&nbsp;certain medications (tranilast, mitomycin C).&nbsp;Non-steroidal anti-inflammatory drugs (NSAIDs),&nbsp;such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682878.html\" target=\"_blank\">aspirin</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682159.html\" target=\"_blank\">ibuprofen</a>, and&nbsp;antihistamines have been used as the primary management of choice with good results. <a href=\"http://www.nlm.nih.gov/medlineplus/antibiotics.html\" target=\"_blank\">Antibiotics</a> are helpful, especially in those individuals with EC associated with <a href=\"http://www.nlm.nih.gov/medlineplus/urinarytractinfections.html\" target=\"_blank\">urinary tract infections</a>. Those&nbsp;who do not respond to&nbsp;NSAIDs and antihistamines have been treated with corticosteroids. Corticosteroids and antihistamines are used because they suppress the inflammatory reaction in the bladder.[3569] However, symptoms of EC may persist, despite steroid therapy. If symptoms persist after steroid therapy,&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682167.html\" target=\"_blank\">azathioprine</a>&nbsp;or <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html\" target=\"_blank\">cyclosporine</a> can be tried.[3569] Other treatments include <a href=\"http://www.mayoclinic.com/health/drug-information/DR600543\" target=\"_blank\">intravesical dimethylsulfoxide</a>,&nbsp;cyclosporin-A (immunosuppressant drug),&nbsp;and silver nitrate.[3568]<br />\r\n<br />\r\nIn those with bladder lesions, surgery has been successful. Few patients with progressive EC not responding to medical therapy or surgery may be considered for more radical procedures, such as partial/total cystectomy (surgical removal of all or part of the bladder).[3568]","dateModified":"2014-10-31T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":3568,"authors":"Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS","articleTitle":"Eosinophilic cystitis and its management","bookWebsiteJournalTitle":"Int J Clin Pract","date":"2005","volume":"59(3)","pages":"356-60","url":"http://www.ncbi.nlm.nih.gov/pubmed/15857336","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3569,"authors":"van den Ouden D","articleTitle":"Diagnosis and management of eosinophilic cystitis: a pooled analysis of 135 cases","bookWebsiteJournalTitle":"Eur Urol","date":"2000","volume":"37(4)","pages":"386-94","url":"http://www.ncbi.nlm.nih.gov/pubmed/10765067","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4600,"questionText":"What is the prognosis of&nbsp;eosinophilic cystitis?","answerText":"Most patients can be&nbsp;cured, but recurrence is a frequent finding. One study examined 118 patients who were treated for eosinophilic cystitis. Of these, 91 patients (77%) were cured, which was defined as the complete absence of symptoms in the short-term and long-term. However, the recurrence of symptoms has been noted in some affected individuals.[3569]&nbsp;Thus, those with EC require long-term follow-up with relevant blood tests, urine examination, appropriate imaging, and cystoscopy.[3568]","dateModified":"2011-06-02T15:54:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3568,"authors":"Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS","articleTitle":"Eosinophilic cystitis and its management","bookWebsiteJournalTitle":"Int J Clin Pract","date":"2005","volume":"59(3)","pages":"356-60","url":"http://www.ncbi.nlm.nih.gov/pubmed/15857336","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3569,"authors":"van den Ouden D","articleTitle":"Diagnosis and management of eosinophilic cystitis: a pooled analysis of 135 cases","bookWebsiteJournalTitle":"Eur Urol","date":"2000","volume":"37(4)","pages":"386-94","url":"http://www.ncbi.nlm.nih.gov/pubmed/10765067","dateAccessed":"2014-10-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Eosinophilic_cystitis"}